Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India

Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India

Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in RA. Rituximab is a well-established biologic for the ma...

Full description

Saved in:
Bibliographic Details
Main Authors: Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Format: Article
Language:English
Published: SAGE Publishing 2021-01-01
Series:Indian Journal of Rheumatology
Subjects:
b cell depletion therapy
biological
biosimilar
disease-modifying antirheumatic drugs
rheumatoid arthritis
rituximab
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=3;spage=311;epage=321;aulast=Talari
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=3;spage=311;epage=321;aulast=Talari

Similar Items